Antidyslipidemics Market Forecast now Available at ReportsandReports

DALLAS, September 21, 2010 – ReportsandReports announces it will carry Antidyslipidemics Market
Forecast Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/reports/7193-antidyslipidemics-market-foreca
st.html
(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser's URL address field. Remove the
space if [...]

immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio

New Investment Allows immatics to Perform Pivotal Study With its Lead Vaccine IMA901 in Patients With Renal Cell Carcinoma (RCC) – Study to Start in 2010

TUEBINGEN, Germany, September 21, 2010 – immatics biotechnologies GmbH, a biopharmaceutical company
developing advanced therapeutic vaccines that are active against cancer,
announced today that it has raised EUR53.8million in a Series [...]

PROMUS(R) Element(TM) Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries

NATICK, Massachusetts, September 21, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced that
its PROMUS(R) Element(TM) Everolimus-Eluting Coronary Stent System has
received CE Mark approval for use in patients with diabetes[1] and those
experiencing an acute myocardial infarction (AMI), or heart attack.

"We are pleased to receive these expanded indications for the
high-risk diabetic [...]

Wake Up and Find the Coffee With Macmillan’s Free iPhone App

…and Why Not Donate the Price of One Whilst You Sip Away!
LONDON, September 21, 2010 – The Macmillan Coffee Finder is a new free app from Macmillan Cancer
Support to help people find the best cup of coffee nearest to them. Starting
off with over 900 caf??s and coffee shops reviewed and rated around the UK,
users [...]

Almac’s Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection

YARDLEY, Pennsylvania, September 21, 2010 – Almac's Clinical Technologies division announced today that it had
successfully passed one of the UK's first joint routine GCP/GMP Medicines and
Healthcare Products Regulatory Agency (MHRA) inspections at its Craigavon, UK
site. This involved senior MHRA inspectors from both its GCP and GMP areas
assessing compliance with UK and European legislation.

[...]

Extensi??n del programa mundial de estudios cl??nicos de la vacuna contra el dengue de Sanofi Pasteur a Brasil

Un nuevo estudio para acelerar el desarrollo de una vacuna innovadora contra el dengue, en uno de los pa??ses m??s afectados del mundo

SAO PAULO, September 21, 2010 – Sanofi Pasteur, la divisi??n vacunas del Grupo Sanofi-aventis,
anunci?? hoy el inicio de un nuevo estudio cl??nico con ni??os y adolescentes,
en Brasil, dentro del programa de desarrollo [...]